The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

A Review of the Use of Electroconvulsive Therapy

Published Online:https://doi.org/10.1176/ps.33.6.469

ECT is an effective psychiatric treatment for severe depression, mania, catatonic states, and, to a lesser degree, some schizophrenias. Complications are minimal and the risk of death extremely low, lower than that for an inadequately treated depression. However, some medical centers in the United States do not use ECT at all. The neurochemical mechanisms that underlie ECT remain unknown, but a cerebral seizure is essential. The average number of treatments is seven, spread over two to three weeks. All candidates for ECT should undergo a complete medical evaluation and give informed consent.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.